Relevance of high Ki-67 in pituitary adenomas. Case report and review of the literature
- PMID: 16398461
- DOI: 10.3171/foc.2005.19.5.12
Relevance of high Ki-67 in pituitary adenomas. Case report and review of the literature
Abstract
Pituitary adenomas are heterogeneous in growth rate, invasiveness, and recurrence. To understand the biological behavior of the individual adenoma more fully, cell proliferation markers such as monoclonal antibodies targeted against the Ki-67 antigen have been applied. The Ki-67 antigen is a protein related to cell proliferation and is expressed in cell nuclei throughout the entire cell cycle. The authors report the case of an extremely rapidly growing pituitary adenoma with cavernous sinus invasion. The lesion, which displayed a high Ki-67 labeling index (LI; 22%), was found in a 54-year-old woman who presented with diplopia and headaches. The patient underwent three transsphenoidal operations in less than 6 months and, ultimately, was treated with fractionated intensity-modulated radiation therapy. The relationships between high Ki-67 LIs and tumor recurrence, invasiveness, and growth velocity in pituitary adenomas are reviewed.
Similar articles
-
The Prognostic Roles of the Ki-67 Proliferation Index, P53 Expression, Mitotic Index, and Radiological Tumor Invasion in Pituitary Adenomas.Endocr Pathol. 2019 Mar;30(1):49-55. doi: 10.1007/s12022-018-9563-2. Endocr Pathol. 2019. PMID: 30610566
-
Labeling index in pituitary adenomas evaluated by means of MIB-1: is there a prognostic role? A critical review.Neurol Res. 2010 Dec;32(10):1060-71. doi: 10.1179/016164110X12670144737855. Epub 2010 May 18. Neurol Res. 2010. PMID: 20483025 Review.
-
Determination of Ki-67 labeling index in pituitary adenomas using MIB-1 monoclonal antibody.Neurol India. 2001 Jun;49(2):144-7. Neurol India. 2001. PMID: 11447433
-
Multiregional sampling reveals a homogenous distribution of Ki-67 proliferation rate in pituitary adenomas.Acta Neurochir (Wien). 2004 Dec;146(12):1323-7; discussion 1327-8. doi: 10.1007/s00701-004-0390-5. Epub 2004 Oct 11. Acta Neurochir (Wien). 2004. PMID: 15480830
-
Ki-67 in pituitary neoplasms: a review--part I.Neurosurgery. 2009 Sep;65(3):429-37; discussion 437. doi: 10.1227/01.NEU.0000349930.66434.82. Neurosurgery. 2009. PMID: 19687686 Review.
Cited by
-
Malignant Leydig cell tumor in dogs: two cases and a review of the literature.J Vet Diagn Invest. 2019 Jul;31(4):557-561. doi: 10.1177/1040638719854791. Epub 2019 Jun 28. J Vet Diagn Invest. 2019. PMID: 31248354 Free PMC article. Review.
-
The impact of immunohistochemical markers of Ki-67 and p53 on the long-term outcome of growth hormone-secreting pituitary adenomas: A cohort study.Asian J Neurosurg. 2014 Jul-Sep;9(3):130-6. doi: 10.4103/1793-5482.142732. Asian J Neurosurg. 2014. PMID: 25685203 Free PMC article.
-
Freiburg Neuropathology Case Conference : A Pituitary Mass Lesion.Clin Neuroradiol. 2016 Dec;26(4):493-497. doi: 10.1007/s00062-016-0549-5. Clin Neuroradiol. 2016. PMID: 27830265 No abstract available.
-
High Ki-67 expression is associated with prolactin secreting pituitary adenomas.Bosn J Basic Med Sci. 2017 May 20;17(2):104-108. doi: 10.17305/bjbms.2017.1750. Bosn J Basic Med Sci. 2017. PMID: 28432860 Free PMC article.
-
Phospho-histone H3 (pHH3) immuno-reactivity as a prognostic marker in non-functioning pituitary adenomas.Pituitary. 2012 Dec;15(4):556-61. doi: 10.1007/s11102-011-0367-3. Pituitary. 2012. PMID: 22120760 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical